title: [Neurological deficits in patients with primary and secondary anticardiolipin syndrome].
abstract: 27 patients (22 women, 5 men); age 17 to 56 yr. (mean age 37 yr.) were included in this study, 4 had primary antiphospholipid syndrome and 18 secondary antiphospholipid syndrome in the course of systemic connective tissue disease and in 5 cases increased levels of anticardiolipid antibodies were found which did not meet the criteria necessary for diagnosis of secondary antiphospholipid syndrome. The mean duration of the disease was 8 yrs. Among primary antiphospholipid syndrome patients two had ischaemic stroke, one migraine-like headache and seizures. 18 patients had lupus erythematosus, two mixed connective tissue disease, one rheumatoid arthritis, one Sjögren syndrome, one Behçet disease. In 55% of patients migraine-like headache, polyneuropathies, encephalophaties, stroke, seizures and vision disturbances were present. In 18.5% of patients EEG exam revealed focal lesions with tendency for generalisation. On brain stem auditory evoked potentials examination, in 11.1% of patients conductivity lesions in mesencephalon and pons were found, visual evoked potentials, in 11.1% of patients in visual tracts. In 37% of patients, neuropathy was found on EMG exam. Neurological symptoms are one of the most frequent disorders in systemic connective tissue disease associated with the presence of anicardiolipin antibodies.
authors.affiliation: Katedry i Kliniki Neurologii PAM w Szczecinie. khonczar@r1.pam.szczecin.pl
authors.forename: K
authors.initials: K
authors.lastname: Honczarenko
authors.forename: L
authors.initials: L
authors.lastname: Ostanek
authors.forename: H
authors.initials: H
authors.lastname: Grzelec
authors.forename: A
authors.initials: A
authors.lastname: Fabian
authors.forename: I
authors.initials: I
authors.lastname: Fiedorowicz-Fabrycy
authors.forename: C
authors.initials: C
authors.lastname: Fryze
mesh_terms: D000293:Adolescent; D000328:Adult; D017153:Antibodies, Anticardiolipin / Q000276:immunology*; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000276:immunology*; D001921:Brain / Q000098:blood supply; D002545:Brain Ischemia / Q000150:complications* / Q000175:diagnosis; D003240:Connective Tissue Diseases / Q000150:complications / Q000276:immunology; D004569:Electroencephalography; D004576:Electromyography; D004797:Enzyme-Linked Immunosorbent Assay; D016057:Evoked Potentials, Auditory, Brain Stem / Q000502:physiology; D005074:Evoked Potentials, Visual / Q000502:physiology; D005121:Extremities / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008636:Mesencephalon / Q000503:physiopathology; D008875:Middle Aged; D009431:Neural Conduction / Q000502:physiology; D011149:Pons / Q000503:physiopathology
chemical_list: D017153:Antibodies, Anticardiolipin